Description

You will lead EU Joint Clinical Assessments (JCA) and Joint Scientific Consultations (JSC) across Revolution Medicines' oncology portfolio. You'll own the end-to-end JCA dossier, coordinate cross-functional teams, and translate JCA outcomes into country-ready materials to enable national HTA submissions and access strategies.

Requirements

• Experience in health technology assessment (HTA) strategy, preferably in oncology
• Expert knowledge of EU HTA regulations and JCA processes
• Strong leadership and cross-functional coordination skills
• Ability to translate HTA requirements into evidence generation strategies
• Experience managing external vendors and partnerships

Responsibilities

• Lead EU JCA execution across oncology programs, ensuring high-quality, on-time submissions
• Establish JCA governance, cross-functional teams, and escalation pathways
• Coordinate JCA scoping, PICO projection, and evidence package delivery
• Partner with Biostatistics and cross-functional teams to deliver JCA-relevant analyses
• Lead interactions with HTA assessors, including responses to questions and factual accuracy reviews